Prim, S.A. 0FP0.L Stock
Prim, S.A. Price Chart
Prim, S.A. 0FP0.L Financial and Trading Overview
| Prim, S.A. stock price | 10.2 EUR |
| Previous Close | 11 EUR |
| Open | 0 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 0 - 0 EUR |
| 52 Week Range | 0 - 11.65 EUR |
| Volume | 0 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.110396035 |
| EPS (TTM) | 1.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0FP0.L Valuation Measures
| Enterprise Value | 190.13M EUR |
| Trailing P/E | 0.110396035 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.5286536 |
| Enterprise Value/Revenue | 0.964 |
| Enterprise Value/EBITDA | 10.771 |
Trading Information
Prim, S.A. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -4.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.65 EUR |
| 52 Week Low | 0 EUR |
| 50-Day Moving Average | 11.01 EUR |
| 200-Day Moving Average | 11.01 EUR |
0FP0.L Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 1 EUR |
| Shares Outstanding | N/A |
| Float | 8.51M |
| Short Ratio | N/A |
| % Held by Insiders | 49.78% |
| % Held by Institutions | 13.19% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 4.28% |
| Operating Margin (ttm) | 4.70% |
| Gross Margin | 46.42% |
| EBITDA Margin | 8.94% |
Management Effectiveness
| Return on Assets (ttm) | 3.19% |
| Return on Equity (ttm) | 7.00% |
Income Statement
| Revenue (ttm) | 197.24M EUR |
| Revenue Per Share (ttm) | 11.68 EUR |
| Quarterly Revenue Growth (yoy) | 126.09% |
| Gross Profit (ttm) | 91.56M EUR |
| EBITDA | 17.65M EUR |
| Net Income Avi to Common (ttm) | 8.45M EUR |
| Diluted EPS (ttm) | 1.01 |
| Quarterly Earnings Growth (yoy) | -52.40% |
Balance Sheet
| Total Cash (mrq) | 14.99M EUR |
| Total Cash Per Share (mrq) | 0.91 EUR |
| Total Debt (mrq) | 22.03M EUR |
| Total Debt/Equity (mrq) | 18.39 EUR |
| Current Ratio (mrq) | 2.775 |
| Book Value Per Share (mrq) | 7.294 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.89M EUR |
| Levered Free Cash Flow (ttm) | -14249117 EUR |
Profile of Prim, S.A.
| Country | United Kingdom |
| State | N/A |
| City | Móstoles |
| Address | Calle Yolanda GonzAlez, number 15 |
| ZIP | 28938 |
| Phone | 34 91 334 24 00 |
| Website | https://www.prim.es |
| Industry | |
| Sector(s) | |
| Full Time Employees | 827 |
Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
Q&A For Prim, S.A. Stock
What is a current 0FP0.L stock price?
Prim, S.A. 0FP0.L stock price today per share is 10.2 EUR.
How to purchase Prim, S.A. stock?
You can buy 0FP0.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Prim, S.A.?
The stock symbol or ticker of Prim, S.A. is 0FP0.L.
How many shares does Prim, S.A. have in circulation?
The max supply of Prim, S.A. shares is 0.
What is Prim, S.A. Price to Earnings Ratio (PE Ratio)?
Prim, S.A. PE Ratio is 0.10099010 now.
What was Prim, S.A. earnings per share over the trailing 12 months (TTM)?
Prim, S.A. EPS is 1.01 EUR over the trailing 12 months.